Clinical Trials Directory

Trials / Sponsors / Prothena Biosciences Ltd.

Prothena Biosciences Ltd.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingPhase 1 Study of PRX019 in Healthy Adult Volunteers
Healthy Participants Study
Phase 12024-11-08
TerminatedA Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis
Light Chain (AL) Amyloidosis
Phase 32021-08-30
TerminatedStudy in Subjects With Light Chain (AL) Amyloidosis
AL Amyloidosis
Phase 22017-06-14
CompletedThe PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyl
AL Amyloidosis
Phase 22016-03-01
TerminatedOpen-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis
AL Amyloidosis
Phase 22016-02-01
CompletedQuality of Life (QOL) Registry for Patients With AL Amyloidosis
AL Amyloidosis, Amyloidosis
—2015-10-01
TerminatedThe VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloi
Primary Systemic (AL) Amyloidosis
Phase 32015-02-01
CompletedPhase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis
Primary Amyloidosis
Phase 1 / Phase 22013-04-01